#South Korea #Seoul #dental 3D printing #CE-MDR #Graphy Inc

Graphy Inc. Achieves CE-MDR Compliance for Dental 3D Printing Materials

Graphy Inc., a trailblazer in the dental technology landscape, has made significant strides by successfully completing the final conformity assessment under the EU's Medical Device Regulation (CE-MDR) for five key dental 3D printing materials. This achievement further solidifies the company's position as a leader in the direct 3D-printed Shape Memory Aligners (SMA™) sector, a groundbreaking advancement aimed at revolutionizing orthodontic treatments.

Overview of the CE-MDR Review Process

The CE-MDR stands for the European Union's Medical Device Regulation, which has stringent requirements for ensuring safety and efficacy in medical devices. Compared to its predecessor, the Medical Devices Directive (MDD), the CE-MDR mandates more detailed clinical evidence, technical documentation, and rigorous risk management practices.

Graphy’s recent review encompassed five materials from its TeraHarz range, specifically three from the TeraHarz Clear series (TC-85DAC, TA-28, TR-07) and two from the TeraHarz series (TC-80DC and BR-23). The comprehensive evaluation process ensures that not only the materials' safety and performance are validated, but also that Graphy’s quality management systems are capable of managing safety across the product lifecycle.

Strengthening Global Presence in Europe

With the completion of this review, Graphy Inc. is poised to expand its manufacturing and distribution capabilities within Europe. The company is not merely focusing on exporting materials but is transitioning towards a business model that emphasizes collaboration with local partners. For instance, Graphy has a prominent partnership with Smilers, a leading brand in clear aligners under Biotech Dental, based in France. This collaboration aims to explore new avenues for product validation and distribution, leveraging Graphy’s proprietary technology.

By integrating local manufacturing with distribution networks in Europe, Graphy expects to significantly enhance its market reach while minimizing the costs associated with establishing direct manufacturing facilities. This strategy supports a recurring revenue model through ongoing materials supply, thereby ensuring sustainable growth.

Implications for the Orthodontics Market

The implications for the orthodontics market are substantial. The Shape Memory Aligner, developed by Graphy, is particularly noteworthy for its innovative use of shape-memory materials, which provide consistent orthodontic forces compared to traditional thermoformed aligners. This unique selling proposition is expected to offer Graphy a competitive edge in the rapidly evolving field of digital orthodontics.

Moreover, as Graphy continues to build on its regulatory achievements—including securing FDA 510(k) clearance and obtaining registrations in several key markets such as Brazil—the company is well-positioned to enhance its influence not just in Europe but across global markets.

Chairman Un Seob Sim emphasized the significance of this achievement by stating, “Completing the final CE-MDR review is vital as it validates five of our core dental 3D printing materials against the stringent standards of the EU medical device regulations. This will facilitate the expansion of our local manufacturing and distribution partnerships, ultimately translating our proprietary materials technology into tangible orders and revenue.”

Conclusion

As Graphy Inc. continues to advance its technological capabilities while expanding its global partnerships, its focus remains on providing innovative solutions for dental professionals and maintaining the highest standards for patient safety and product efficacy. This latest development in obtaining CE-MDR certification is a significant milestone, reflecting the company’s commitment to quality and innovation in the dental care industry.

With continuous improvement and investment in its technology and partnerships, Graphy is set to redefine standards in the orthodontic market and foster worldwide collaboration that ultimately benefits practitioners and patients alike.